Skip to content

Development and Application of a Risk Warning System for Venous Thromboembolism in Gynecological Malignant Tumor Surgery Patients Based on Machine Learning Algorithms

Development and Application of a Risk Warning System for Venous Thromboembolism in Gynecological Malignant Tumor Surgery Patients Based on Machine Learning Algorithms

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123302
Enrollment
Unknown
Registered
2026-04-23
Start date
2026-04-30
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous Thromboembolism

Interventions

Case group:None

Sponsors

The first affiliated Hospital of henan university of science & technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years; 2. First occurrence with the primary lesion located in the female reproductive system, pathologically confirmed as a gynecologic malignant tumor (cervical cancer, ovarian cancer, endometrial cancer) and undergoing surgery; 3. The patient has complete laboratory tests (D-dimer, platelet count, hemoglobin, prothrombin time, fibrinogen, serum homocysteine, etc.) and auxiliary examinations (bilateral lower limb venous ultrasound); 4. Agrees to participate in this study and has signed the informed consent form;

Exclusion criteria

Exclusion criteria: 1.The patient was previously diagnosed with DVT or PE, or there was already an arterial or venous embolism in another part of the body; 2.Those with severe psychological and mental disorders, abnormal cognitive and behavioral abilities, and poor compliance; 3.Those with neurological deficits or nerve paralysis.

Design outcomes

Primary

MeasureTime frame
Specificity;Sensitivity;

Countries

China

Contacts

Public ContactLijun

The first affiliated Hospital of henan university of science & technology

865585043@qq.com+86 379 64922216

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026